null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
VASCULAR COMPLICATIONS
News
Sanofi-Aventis' Semuloparin May Have Safety Advantage for ODAC to Consider
The Pink Sheet Daily, 2012 Apr 26, M Berman-Gorvine
Adding Bevacizumab to Chemo Raises Treatment-Related Mortality
Elsevier Global Medical News, 2011 Feb 2, MA Moon
Blood Clot Risk Causes Lilly, Bristol to Halt Enrollment in Erbitux Follow-on Trial
The Pink Sheet Daily, 2011 Feb 2, J Haas
Thrombosis Risk Rises in Women With Myeloproliferative Disorders
Elsevier Global Medical News, 2010 Dec 20, H Splete
Study Shows Rivaroxaban Valid for VTE Prophylaxis
Elsevier Global Medical News, 2010 Dec 6, N Osterweil
More News ›
Journal Scans
Thyroid Gland Papillary Carcinomas With "Micropapillary Pattern," A Recently Recognized Poor Prognostic Finding: Clinicopathologic and Survival Analysis of 7 Cases
Hum Pathol, 2012 Mar 16, LS Lino-Silva, et al
Defibrotide for Prophylaxis of Hepatic Veno-Occlusive Disease in Paediatric Haemopoietic Stem-Cell Transplantation: An Open-Label, Phase 3, Randomised Controlled Trial
Lancet, 2012 Feb 22, S Corbacioglu, et al
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
N Engl J Med, 2012 Feb 16, G Agnelli, et al
Risk of Haemorrhagic and Ischaemic Stroke in Patients With Cancer: A Nationwide Follow-Up Study From Sweden
Eur J Cancer, 2012 Jan 30, B Zoller, et al
Risk of Venous and Arterial Thromboembolic Events Associated With Anti-EGFR Agents: A Meta-Analysis of Randomized Clinical Trials
Ann Oncol, 2012 Jan 11, F Petrelli, et al
More Journal Scans ›
All Journals
Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials
Blood Rev, 2011 May 1, Jeremy S. Paikin, et al
Autopsy After Traumatic Death—A Shifting Paradigmnull
J Surg Res, 2011 May 1, Timothy D. Light, et al
An Unusual Cause of Leg Ulcerations
Am J Med, 2011 Apr 1, Manuela L. Moscaliuc, et al
Morbidity and mortality after hepatic and pancreatic resections: results from one surgeon at a low-volume urban hospital over thirty years
Am J Surg, 2011 Apr 1, Gary S. Schwartz, et al
The impact of co-morbid conditions on family history of venous thromboembolism in Whites and Blacks
Thromb Res, 2011 Apr 1, Fatima D. Mili, et al
More All Journals ›
Expert Opinion
Update on Novel Anticoagulants
2011 Sept 26, David Henry, et al
Dr. David Henry: We Should Be Thinking About Primary VTE Prophylaxis
OncologySTAT Editorial Team, 2011 Feb 16, Intervew by L Scott Zoeller
Understanding VTE Risk in Ambulatory Cancer Patients: Just Beginning to Scratch the Surface
Top Stories of 2009, 2010 Jan 1
Preventing VTE in Ambulatory Cancer Patients: A Question of Risk
2009 Feb 17, David Henry, et al
Interview With Drs. Lee Schwartzberg and David Henry Part 2
Linda Bosserman for the OncologySTAT Editorial Team, 2008 Feb 14
Videos
Prophylaxis Cuts Thromboembolic Events
Elsevier Global Medical News, 2008 Dec 7, JS MacNeil
Triple Therapy for CLL
Elsevier Global Medical News, 2008 Dec 7, R Finn
Comment
Print page
Share page
RSS feeds
Editors' Choice
Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
General/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.